Polymerase Acidic Endonuclease Inhibitors [MoA] - N0000193853

Pharmacologic Code	N0000193853
Pharmacologic Name	Polymerase Acidic Endonuclease Inhibitors
Pharmacologic Uses	polymerase acidic (PA) endonuclease inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Polymerase Acidic Endonuclease Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50242-583	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Granule, For Solution	Oral	Genentech, Inc.	ACTIVE
	50242-599	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Granule, For Suspension	Oral	Genentech, Inc.	ACTIVE
	50242-617	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Granule, For Suspension	Oral	Genentech, Inc.	ACTIVE
	50242-860	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Tablet, Film Coated	Oral	Genentech, Inc.	ACTIVE
	50242-877	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Tablet, Film Coated	Oral	Genentech, Inc.	ACTIVE
	85766-058	Xofluza	Non-Proprietary Name: Baloxavir Marboxil	Tablet, Film Coated	Oral	Sportpharm, Inc. Dba Sportpharm	ACTIVE